Clinical Trial Update: EGCG for Hepatocellular Carcinoma Chemoprevention [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating epigallocatechin gallate (EGCG) for chemoprevention of hepatocellular carcinoma in patients with cirrhosis; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma

Drugs mentioned

• EGCG (epigallocatechin gallate)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cirrhosis, Liver | Phase 2 | Status: RECRUITING